DAWN - Day One Biopharmaceuticals Inc
Day One Biopharmaceuticals Inc Logo

DAWN - Day One Biopharmaceuticals Inc

https://dayonebio.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and markets targeted therapies for patients with genetically defined cancers. The company is headquartered in South San Francisco, California.

52W High
$16.76
52W Low
$5.63
MA Status:
50D: Above 200D: Below
Beta (~1 neutral, <0.9 lower risk)
-1.26
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-7.18
EV/Revenue (<3 favorable)
1.72
P/S (TTM) (<3 favorable)
4.12
P/B (<3 favorable)
1.68
Ownership
Institution‑heavy
Source: Overview
Insiders (1–5% typical)
16.94%
Institutions (25–75% balanced)
85.68%
Shares Outstanding
102,432,000
Float
78,723,000
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
187,638,000
Gross Profit (TTM)
176,417,000
EPS (TTM)
-0.89
Profit Margin (>10% good)
-0.51%
Operating Margin (TTM) (higher better)
-1.03%
ROE (TTM) (>15% strong)
-0.25%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
3.14
Momentum
Bearish momentum
Value
0.1815
Previous
0.2238
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025